Golden Helix Named to the 2019 Inc. 5000 List of Fastest-Growing Private Companies
September Newsletter
We're headed to ASHG!

We're headed to ASHG!
Houston, Texas |  October 15-19, 2019
Booth #601

We hope you will stop by our booth #601 for a demo or one of our CoLab presentations over in Theatre 3:

Wed, Oct 16, 12:45-1:30 pm Clinical Variant Analysis: Applying the AMP & ACMG Guidelines in the Clinical Practice

Thurs, Oct 17, 12:45-1:30 pm State of the Art Clinical Copy Number Variant Analysis in Next-Gen Sequencing Data: Gene Panels, Whole Exome, Whole Genome

See our full demo schedule, or request a one-on-one meeting with our team here.

 Following the AMP Guidelines with VSClinical: Part I

Following the AMP Guidelines with VSClinical Blog Series
By Gabe Rudy
VP of Product & Engineering

In the world of genomics shaping precision medicine in oncology, the limiting factor is the time-to-sign-out of a fully interpreted molecular profile report. There are many components of the entire testing process that add to the turn-around time of each test. Many of these steps, such as sample prep, sequencing, and automated secondary analysis, are bounded and consistent in their time requirements. The hands-on... Read More

Getting the most out of Sentieon

Getting the most out of Sentieon
By Will McDonald
Sentieon Support Technician

Customers are always asking for ways to improve their experience with Sentieon, our partner’s secondary analysis tools that process genomics data with high computing efficiency, fast turnaround time, exceptional accuracy and 100% consistency. We have a few tips to get the most out of Sentieon. In this article, I will be going over basic system requirements and custom scripts vs default scripts... Read More

Automating & Standardizing Your NGS Workflow

Automating & Standardizing Your NGS Workflow Blog Series
By Darby Kammeraad
Field Application Scientist Manager

This blog series will supply some insight into optimizing a full high throughput bioinformatics pipeline from FASTQ to clinical report. Our full software stack not only produces top quality variant calling and interpretation with our secondary and tertiary capabilities but also provides the means of storing your complete set of genomic data in VSWarehouse. Users can then leverage this collection of stored data against future samples to isolate rare variants... Read More

CEO Corner
New eBook: Clinical Variant Analysis for Cancer
The first nine months of this year have been incredibly busy for us, it’s hard to believe that there are only three months left! We started the year off with the release of our AMP Cancer Workflow to VSClinical and have been keeping busy with a variety of revisions to our solutions.  Our hard work paid off when we were named as one of the fastest growing private companies by Inc. 5000 for 2019. As the end of the year approaches, we’re still in full gear as we head to ASHG in Houston, TX. If you will be attending and have the opportunity to stop by our booth, please do so – we will be in booth #601 and would be delighted to connect with you in person.
Upcoming Webcast

Clinical Validation of Copy Number Variants Using the AMP Guidelines  
October 9, 2019 | 12:00 PM Eastern

The common approaches to detecting copy number variants (CNVs) are chromosomal microarray and MLPA. However, both options increase analysis time, per sample costs, and are limited to the size of CNV events that can be detected. VarSeq’s CNV caller, on the other hand, allows users to detect CNVs from the coverage profile stored in the BAM file, which allows you to utilize your existing NGS data and perform the analysis all in one suite...

Register
Customer Success

Our customers have published a number of fascinating articles throughout September! To highlight just a couple:

"Rectal Cancer Sub-clones Respond Differentially to Neoadjuvant Therapy" Peter Ulintz & Colleagues, University of Michigan / Published in Science Direct - Neoplasia

"Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses" Rebecca R. Bellone & Colleagues, University of California, Davis / Published in the International Journal of Genomics

Read more about the articles published this month on our blog!

About Golden Helix

Golden Helix has been delivering industry-leading bioinformatics solutions for the advancement of life science research and translational medicine for over 20 years with 1,000s of users around the world. Their innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from NGS sequencers and microarrays. With their solutions, hundreds of the world's top hospitals, testing labs, pharmaceutical, biotech, and academic research organizations can harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine.